Top Ten Holdings
Summary by AI BETAClose X
Hansa Investment Company Limited
At close of business on 28th February 2026 the Company held the following investments with a value greater than 5% of gross assets or were at least the 10 largest holdings, a declaration of which is required quarterly under the Listing Rules; however Hansa Investment Company Limited has decided to declare this information on a monthly basis:
|
|
% |
|
iShares Core S&P 500 UCITS ETF |
9.0 |
|
Life Cycle US Equity Fund - UCITS |
4.3 |
|
Helikon Long Short Equity Fund ICAV |
3.0 |
|
Polar Capital Fund - Global Technology |
2.8 |
|
iShares Core MSCI Europe UCITS ETF |
2.7 |
|
Schroder ISF Asian Total Return |
2.3 |
|
BlackRock Strategic Equity Hedge Fund |
2.1 |
|
Findlay Park American Fund |
2.1 |
|
iShares Expanded Tech Sector ETF |
2.1 |
|
iShares MSCI EM Asia UCITS ETF |
1.9 |
|
Total |
32.4 |
|
Cash (including liquidity funds)* |
24.3 |
*The cash from the sale of Wilson Sons is being deployed on a quarterly basis over the course of one year, although the Investment Advisor retains the ability to vary this if market opportunities arise. The first tranche of cash was deployed at the end of December 2025.
Hansa Capital Partners LLP
Additional Administrative Services Provider to Hansa Investment Company Limited
020 7647 5750
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Companies
Hansa Investment Company Limited (DI) (HAN)Hansa Investment Company Limited 'A' Non Vtg (DI) (HANA)
Latest directors dealings
- 37 minutes ago Prudential
- 49 minutes ago Vanquis Banking Group 20
- 3 hours ago Frasers Group
- 3 hours ago Cavendish Financial
- 3 hours ago Diaceutics